Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Roche describes antiproliferative agents

Jan. 10, 1997

Preclinical pharmacology profile of BMS NEP/ACE inhibitors described

Jan. 8, 1997

Tokyo Tanabe describes agents for cardiovascular/respiratory disorders

Jan. 8, 1997

Beta-blockers underused

Jan. 7, 1997

P&U discontinues development of agent for DVT; Cytel regains development rights

Jan. 7, 1997

Andrx freed to market Dilacor XR bioequivalent

Jan. 3, 1997

bFGF enters clinical trials for PVD

Jan. 3, 1997

T Cell Sciences describes anti-CETP vaccines

Jan. 2, 1997

Nissan Chemical discloses novel cardiovascular agents

Jan. 2, 1997

FDA clears angiotensin II blocker from Ciba

Dec. 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...